A platform for research: civil engineering, architecture and urbanism
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024)
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024)
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024)
Advanced Science
Acúrcio, Rita C. (author) / Kleiner, Ron (author) / Vaskovich‐Koubi, Daniella (author) / Carreira, Bárbara (author) / Liubomirski, Yulia (author) / Palma, Carolina (author) / Yeheskel, Adva (author) / Yeini, Eilam (author) / Viana, Ana S. (author) / Ferreira, Vera (author)
Advanced Science ; 11
2024-10-01
Article (Journal)
Electronic Resource
English
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Wiley | 2024
|Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Wiley | 2024
|Wiley | 2024
|